Aegerion Pharmaceuticals, Inc. (AEGR) Tops Q4 EPS by 16c

February 26, 2014 7:35 AM EST Send to a Friend
Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) reported Q4 EPS of ($0.14), $0.16 better than ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login